Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone

Circulation

Volumn 132, Issue 5, 2015, Pages 402-414

  Shah, Amil M ^a   Claggett, Brian ^a   Sweitzer, Nancy K ^b   Shah, Sanjiv J ^c   Anand, Inder S ^d   Liu, Li ^a   Pitt, Bertram ^e   Pfeffer, Marc A ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

clinical trial; heart failure; heart ventricles; preserved left ventricular function; spironolactone; strain

Indexed keywords

BIOLOGICAL MARKER; SPIRONOLACTONE; MINERALOCORTICOID ANTAGONIST;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FEMALE; HEART ARREST; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPECKLE TRACKING ECHOCARDIOGRAPHY; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART FAILURE, SYSTOLIC; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INCIDENCE; INTERNATIONAL COOPERATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HEART FAILURE, SYSTOLIC; HOSPITALIZATION; HUMANS; INCIDENCE; INTERNATIONALITY; MALE; MIDDLE AGED; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROGNOSIS; SPIRONOLACTONE; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84939547364     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.015884     Document Type: Article

References (54)

1. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP, Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006 355 260 269. doi: 10.1056/NEJMoa051530
2. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM, Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006 355 251 259. doi: 10.1056/NEJMoa052256
3. Tsutsui H, Tsuchihashi M, Takeshita A, Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001 88 530 533
4. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM, Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003 41 1510 1518
5. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D, Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999 33 1948 1955
6. Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S, ALLHAT Collaborative Research Group Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2008 118 2259 2267. doi: 10.1161/CIRCULATIONAHA.107.762229
7. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL, How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 28 2539 2550. doi: 10.1093/eurheartj/ehm037
8. Abhayaratna WP, Marwick TH, Smith WT, Becker NG, Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006 92 1259 1264. doi: 10.1136/hrt.2005.080150
9. Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, McKelvie RS, Investigators of the CHARM Echocardiographic Substudy-CHARMES Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007 49 687 694. doi: 10.1016/j.jacc.2006.08.062
10. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE, I-PRESERVE Investigators Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 2011 124 2491 2501. doi: 10.1161/CIRCULATIONAHA.110.011031
11. Petrie MC, Caruana L, Berry C, McMurray JJ, "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002 87 29 31
12. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE, Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002 87 121 125
13. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW, Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 2002 105 1195 1201
14. Cioffi G, Senni M, Tarantini L, Faggiano P, Rossi A, Stefenelli C, Russo TE, Alessandro S, Furlanello F, de Simone G, Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study). Am J Cardiol 2012 109 383 389. doi: 10.1016/j.amjcard.2011.09.022
15. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG, "Pure" diastolic dysfunction is associated with long-Axis systolic dysfunction: implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005 7 820 828. doi: 10.1016/j.ejheart.2005.02.003
16. Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM, Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009 54 410 418. doi: 10.1016/j.jacc.2009.05.013
17. Morris DA, Boldt LH, Eichstädt H, Ozcelik C, Haverkamp W, Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction. Circ Heart Fail 2012 5 610 620. doi: 10.1161/CIRCHEARTFAILURE.112.966564
18. Liu YW, Tsai WC, Su CT, Lin CC, Chen JH, Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail 2009 15 782 789. doi: 10.1016/j.cardfail.2009.05.006
19. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD, PARAMOUNT Investigators Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 2014 63 447 456. doi: 10.1016/j.jacc.2013.09.052
20. Shah AM, Solomon SD, Myocardial deformation imaging: current status and future directions. Circulation 2012 125 e244 e248. doi: 10.1161/CIRCULATIONAHA.111.086348
21. Weidemann F, Jamal F, Sutherland GR, Claus P, Kowalski M, Hatle L, De Scheerder I, Bijnens B, Rademakers FE, Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Am J Physiol Heart Circ Physiol 2002 283 H792 H799. doi: 10.1152/ajpheart.00025.2002
22. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ, Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009 54 618 624. doi: 10.1016/j.jacc.2009.04.061
23. Nahum J, Bensaid A, Dussault C, Macron L, Clémence D, Bouhemad B, Monin JL, Rande JL, Gueret P, Lim P, Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 2010 3 249 256. doi: 10.1161/CIRCIMAGING.109.910893
24. Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, Foster E, Zareba W, Goldenberg I, McNitt S, Pfeffer MA, Moss AJ, Solomon SD, Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Investigators Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail 2011 4 433 440. doi: 10.1161/CIRCHEARTFAILURE.111.962902
25. Hung CL, Verma A, Uno H, Shin SH, Bourgoun M, Hassanein AH, McMurray JJ, Velazquez EJ, Kober L, Pfeffer MA, Solomon SD, VALIANT Investigators Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol 2010 56 1812 1822. doi: 10.1016/j.jacc.2010.06.044
26. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, Clausell N, Diaz R, Fleg JL, Gordeev I, McKinlay S, O'Meara E, Shaburishvili T, Pitt B, Pfeffer MA, Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J 2011 162 966 972
27. Shah SJ, Heitner JF, Sweitzer NK, Anand IS, Kim HY, Harty B, Boineau R, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Lewis EF, Markov V, O'Meara E, Kobulia B, Shaburishvili T, Solomon SD, Pitt B, Pfeffer MA, Li R, Baseline characteristics of patients in the Treatment of Preserved Cardiac Function Heart Failure With An Aldosterone Antagonist Trial. Circ Heart Fail 2013 6 184 192. doi: 10.1161/CIRCHEARTFAILURE.112.972794
28. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014 370 1383 1392. doi: 10.1056/NEJMoa1313731
29. Shah AM, Shah SJ, Anand IS, Sweitzer NK, O'Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, TOPCAT Investigators Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial. Circ Heart Fail 2014 7 104 115. doi: 10.1161/CIRCHEARTFAILURE.113.000887
30. The ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989 129 687 702
31. Shah AM, Cheng S, Skali H, Wu J, Mangion JR, Kitzman D, Matsushita K, Konety S, Butler KR, Fox ER, Cook N, Ni H, Coresh J, Mosley TH, Heiss G, Folsom AR, Solomon SD, Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities study. Circ Cardiovasc Imaging 2014 7 173 181. doi: 10.1161/CIRCIMAGING.113.000736
32. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 18 1440 1463. doi: 10.1016/j.echo.2005.10.005
33. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB, Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010 23 685 713
34. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 2014 7 740 751. doi: 10.1161/CIRCHEARTFAILURE.114.001583
35. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003 362 777 781. doi: 10.1016/S0140-6736(03)14285-7
36. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A, I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008 359 2456 2467. doi: 10.1056/NEJMoa0805450
37. Uno H, Tian L, Cai T, Kohane IS, Wei LJ, A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med 2013 32 2430 2442. doi: 10.1002/sim.5647
38. Vasan RS, Levy D, Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000 101 2118 2121
39. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B, Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015 131 34 42. doi: 10.1161/CIRCULATIONAHA.114.013255
40. Pellicori P, Kallvikbacka-Bennett A, Khaleva O, Carubelli V, Costanzo P, Castiello T, Wong K, Zhang J, Cleland JG, Clark AL, Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? Int J Cardiovasc Imaging 2014 30 69 79. doi: 10.1007/s10554-013-0310-y
41. Shah SJ, Aistrup GL, Gupta DK, O'Toole MJ, Nahhas AF, Schuster D, Chirayil N, Bassi N, Ramakrishna S, Beussink L, Misener S, Kane B, Wang D, Randolph B, Ito A, Wu M, Akintilo L, Mongkolrattanothai T, Reddy M, Kumar M, Arora R, Ng J, Wasserstrom JA, Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure. Am J Physiol Heart Circ Physiol 2014 306 H88 H100. doi: 10.1152/ajpheart.00642.2013
42. Imbalzano E, Zito C, Carerj S, Oreto G, Mandraffino G, Cusmà-Piccione M, Di Bella G, Saitta C, Saitta A, Left ventricular function in hypertension: new insight by speckle tracking echocardiography. Echocardiography 2011 28 649 657. doi: 10.1111/j.1540-8175.2011.01410.x
43. Fang ZY, Leano R, Marwick TH, Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond) 2004 106 53 60. doi: 10.1042/CS20030153
44. Stampehl MR, Mann DL, Nguyen JS, Cota F, Colmenares C, Dokainish H, Speckle strain echocardiography predicts outcome in patients with heart failure with both depressed and preserved left ventricular ejection fraction. Echocardiography 2014 00 1 8
45. Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P, Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol 2012 176 473 481. doi: 10.1093/aje/kws207
46. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E, Chow BJ, Min JK, Pencina MJ, Berman DS, Shaw LJ, Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol 2013 61 176 184. doi: 10.1016/j.jacc.2012.09.043
47. Kalogeropoulos AP, Georgiopoulou VV, deFilippi CR, Gottdiener JS, Butler J, Cardiovascular Health Study Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study. JACC Cardiovasc Imaging 2012 5 131 140. doi: 10.1016/j.jcmg.2011.11.011
48. Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N, N-Terminal pro-B-Type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS. Eur Heart J 2013 34 443 450. doi: 10.1093/eurheartj/ehs239
49. Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Loffler M, Dungen H-D, Tschope C, Herrmann-Lingen C, Halle M, Hasenfuss G, Pieske B, Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 2013 309 781 91
50. Deswal A, Richardson P, Bozkurt B, Mann DL, Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail 2011 17 634 642. doi: 10.1016/j.cardfail.2011.04.007
51. Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A, Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail 2014 20 560 568. doi: 10.1016/j.cardfail.2014.05.010
52. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH, Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004 110 558 565. doi: 10.1161/01.CIR.0000138680.89536.A9
53. Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, Marwick TH, Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade. Heart 2013 99 320 326. doi: 10.1136/heartjnl-2012-303329
54. Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, O'Moore-Sullivan T, Marwick TH, A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. JACC Cardiovasc Imaging 2011 4 1239 1249. doi: 10.1016/j.jcmg.2011.08.014